glaucoma/edema

TECHNICAL FIELD The present invention relates to a method for treating ocular hypertension and glaucoma with reduced side effects, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof, which contains substantially no benzalkonium

TECHNICAL FIELD The present invention relates to a method for treating ocular hypertension and glaucoma with reduced side effects, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof, which contains substantially no benzalkonium

FIELD OF THE INVENTION The present invention relates to the field of interfering RNA compositions for inhibition of expression of hypoxia-inducible factor-1.alpha. (HIF-1.alpha.), the protein encoded by HIF1A mRNA, in ocular angiogenesis, including those cellular changes resulting from the

FIELD OF THE INVENTION The present invention relates to improved ophthalmic formulations, particularly to ophthalmic formulations which use an improved preservative system comprising a quaternary ammonium preservative and a stabilizing amount of a nonionic polyoxyethylated octylphenol surfactant for

PRIORITY This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/050899 titled "COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF CARBONIC ANHYDRASE ACTIVITY" filed on Feb. 3, 2013 Published with WIPO Publication # WO/2013/167994, which further

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a method for the treatment of ophthalmic diseases originating from or associated with inflammation. 2. Related Disclosure Many ophthalmic diseases are ocular disorders which are either caused or associated with painful

The present invention relates to the field of ophthalmology. In particular, the present invention relates to the treatment of retinal tissues. More specifically, the present invention discloses compositions and methods of using adenosine uptake inhibitors in the prevention or treatment of retinal

FIELD OF THE INVENTION The present invention relates to novel methods for the treatment or prevention of glaucoma, ocular hypertension, and other ophthalmic disorders exhibiting elevated intraocular pressure, as well as ocular disorders characterized by retinal neurodegeneration or edema including

TECHNICAL FIELD The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating cerebrovascular disorders such as cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral edema, particularly as a

This application is a National Stage of PCT/JP11/069,187 filed Aug. 25, 2011 and claims the benefit of JP 2010-189392 filed Aug. 26, 2010. TECHNICAL FIELD The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating

BACKGROUND Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis, and they regulate angiogenesis in a variety of processes. Undesirable or pathological angiogenesis is associated with diseases including diabetic retinopathy, psoriasis, cancer, rheumatoid

BACKGROUND OF THE INVENTION Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or

BACKGROUND OF THE INVENTION Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or

BACKGROUND OF THE INVENTION Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or

BACKGROUND OF THE INVENTION Growth factors play an important role in angiogenesis, lymphangiogenesis, and vasculogenesis. Growth factors regulate angiogenesis in a variety of processes including embryonic development, wound healing, and several aspects of female reproductive function. Undesirable or